20 July 2020 - Deborah Wilkes
Archived
Novartis has launched a “not-for-profit” portfolio of generic and OTC medicines for symptomatic treatment of COVID-19.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.